Ultra-thinly traded nano cap Entasis Therapeutics Holdings (ETTX +180.6%)
rockets north on a 6x surge in volume, albeit on modest turnover of 72K
shares, apparently being swept up in the market’s frenzied buying of
anything related to COVID-19 treatments or vaccines.
The company has not announced any specific coronavirus programs. It has four candidates in its pipeline, all antibacterials.
https://seekingalpha.com/news/3553080-entasis-therapeutics-up-181-amid-covidminus-19-frenzy
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.